Innovative Technology Allows for Effective Removal of Biofilms
STERIS Corporation have added a biofilm removal label claim in the United States for STERIS ProKlenz® ONE alkaline cleaner following an update of the past registration with the Environmental Protection Agency (EPA). This performance claim, in addition to the product’s claims as a disinfectant and virucide, demonstrates the efficacy of ProKlenz ONE as both a cleaner and disinfectant. This new label claim is the result of extensive testing and development in the removal of biofilms from hard, non-porous surfaces.
“Microbial contamination, specifically biofilms, can be a significant challenge for our Customers,’’ says Michael Gietl, Sr. Product Manager for STERIS Life Sciences. “Years of research and data collection gave us the confidence to pursue this performance claim, and we’ve demonstrated the product’s ability to remove one of the most challenging soils in the pharmaceutical and biopharmaceutical industries.”
ProKlenz ONE alkaline cleaner is a detergent specially formulated to meet the unique cleaning demands found in the pharmaceutical, biotechnology, cosmetic, nutraceutical, and other industries requiring an effective validatable cleaner. It is a high-performance alkaline cleaner that is also a disinfectant and virucide formulated to remove difficult process residues.
A proprietary blend of a concentrated alkalinity source, advanced surfactant system and other performance enhancing ingredients provides multiple cleaning mechanisms and microbial efficacy. This low-foaming product removes a wide range of process residues from fermentation by-products to silicone-based emulsions and lubricants and is ideal for use in CIP and COP applications. An extensive support package is available to meet your validation objectives.
Customers can contact their local STERIS Life Sciences Account Manager for more information or to order.
For more information about this and other STERIS Laboratory technologies, please visit www.sterislifesciences.com
Date Published: 4th January 2019
Source article link: Steris Corporation
New Aspergillus Monoclonal Antibody for
Corning Life Sciences Sample Collection